A review of the genetics of type I diabetes

Abstract

Type I diabetes susceptibility is caused by both environmental and genetic factors, the latter comprising approximately half of the total risk as evidenced by the fact that identical twins have approximately 50% concordance, suggesting 50% of the disease risk is environmental. The human leukocyte antigen (HLA) genes account for approximately half of the genetic risk, as demonstrated by the concordance between HLA identical siblings. Because environmental and genetic differences vary between racial groups, the incidence of type 1 diabetes (TID) differs across the world, being highest in Caucasians. Recent GWAS (genome-wide association studies) studies have suggested there may be up to 50 genomic regions contributing to the non-major histocompatibility complex (MHC) genetic risk contribution. This review presents and discusses the latest research on the MHC and non-MHC genes. Only the non-MHC regions, which have been confirmed in multiple studies and which are considered definite regions of genetic susceptibility, are included in the review.

Keywords

HLA / non-HLA / type I diabetes / genetic association / susceptibility

References

[1] Ravikumar V, Ahmed A, Anjankar A. A Review on Latent Autoimmune Diabetes in Adults. Cureus. 2023; 15: e47915. [DOI] [PubMed] [PMC]

[2] Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, et al. ; Type 1 Diabetes Genetics Consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes. 2005; 54: 2995-3001. [DOI] [PubMed]

[3] Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case Control Consortium. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007; 39: 857-64. [DOI] [PubMed] [PMC]

[4] Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care. 2008; 31: 1546-9. [DOI] [PubMed] [PMC]

[5] Tait BD, Colman PG, Morahan G, Marchinovska L, Dore E, Gellert S, et al. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens. 2003; 61: 146-53. [DOI] [PubMed]

[6] Singal DP, Blajchman MA. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 1973; 22: 429-32. [DOI] [PubMed]

[7] Cudworth AG, Woodrow JC. HL-A system and diabetes mellitus. Diabetes. 1975; 24: 345-9. [DOI] [PubMed]

[8] Conference and Workshop on Histocompatibility Testing. Histocompatibility testing 1977 : report of the 7th International Histocompatibility workshop and conference, the workshop conference took place in Oxford, England from 4-10 September, 1977. 1st ed. Bodmer WF, editor. Copenhagen: Munksgaard; 1978.

[9] Maclaren N, Riley W, Skordis N, Atkinson M, Spillar R, Silverstein J, et al. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective. Autoimmunity. 1988; 1: 197-205. [DOI] [PubMed]

[10] Type 1 Diabetes Genetics Consortium (T1DGC) [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases; [cited 2024 May 23]. Available from: https://repository.niddk.nih.gov/studies/t1dgc/

[11] Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. ; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008; 57: 1084-92. [DOI] [PubMed] [PMC]

[12] Nepom BS, Schwarz D, Palmer JP, Nepom GT. Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes. 1987; 36: 114-7. [DOI] [PubMed]

[13] Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell. 2019; 177: 26-31. [DOI] [PubMed] [PMC]

[14] Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A. 1988; 85: 6012-6. [DOI] [PubMed] [PMC]

[15] Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A. 1988; 85: 8111-5. [DOI] [PubMed] [PMC]

[16] Todd JA, Bell JI, McDevitt HO. A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. Trends Genet. 1988; 4: 129-34. [DOI] [PubMed]

[17] Ronningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol. 1989; 26: 215-25. [DOI] [PubMed]

[18] Tait BD, Mraz G, Harrison LC. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients. Diabetes. 1988; 37: 926-9. [DOI] [PubMed]

[19] Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes. 1990; 39: 96-103. [DOI] [PubMed]

[20] Clark PM, Chitnis N, Shieh M, Kamoun M, Johnson FB, Monos D. Novel and Haplotype Specific MicroRNAs Encoded by the Major Histocompatibility Complex. Sci Rep. 2018; 8: 3832. [DOI] [PubMed] [PMC]

[21] Shieh M, Chitnis N, Monos D. Human Leukocyte Antigen and Disease Associations: A Broader Perspective. Clin Lab Med. 2018; 38: 679-93. [DOI] [PubMed]

[22] Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 2002; 3: 235-49. [DOI] [PubMed]

[23] Howson JMM, Walker NM, Smyth DJ, Todd JA ; Type I Diabetes Genetics Consortium. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun. 2009; 10: S74-84. [DOI] [PubMed] [PMC]

[24] Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A. 1981; 78: 5759-63. [DOI] [PubMed] [PMC]

[25] Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984; 33: 176-83. [DOI] [PubMed]

[26] Pugliese A, Zeller M, Jr AF, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 1997; 15: 293-7. [DOI] [PubMed]

[27] Sobhani N, Tardiel-Cyril DR, Davtyan A, Generali D, Roudi R, Li Y. CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers (Basel). 2021; 13: 1440. [DOI] [PubMed] [PMC]

[28] Nisticò L, Buzzetti R, Pritchard LE, Auwera BVd, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996; 5: 1075-80. [DOI] [PubMed]

[29] Qu H, Bradfield JP, Grant SFA, Hakonarson H, Polychronakos C ; Type I Diabetes Genetics Consortium. Remapping the type I diabetes association of the CTLA4 locus. Genes Immun. 2009; 10: S27-32. [DOI] [PubMed] [PMC]

[30] Julier C, Akolkar B, Concannon P, Morahan G, Nierras C, Pugliese A, et al. ; Type I Diabetes Genetics Consortium. The Type I Diabetes Genetics Consortium ‘Rapid Response’ family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun. 2009; 10: S121-7. [DOI] [PubMed] [PMC]

[31] Liu S, Wang H, Jin Y, Podolsky R, Reddy MVPL, Pedersen J, et al. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet. 2009; 18: 358-65. [DOI] [PubMed] [PMC]

[32] Zurawek M, Fichna M, Fichna P, Skowronska B, Dzikiewicz-Krawczyk A, Januszkiewicz D, et al. Cumulative effect of IFIH1 variants and increased gene expression associated with type 1 diabetes. Diabetes Res Clin Pract. 2015; 107: 259-66. [DOI] [PubMed]

[33] Downes K, Pekalski M, Angus KL, Hardy M, Nutland S, Smyth DJ, et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One. 2010; 5: e12646. [DOI] [PubMed] [PMC]

[34] Domsgen E, Lind K, Kong L, Hühn MH, Rasool O, Kuppeveld Fv, et al. An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets. Sci Rep. 2016; 6: 39378. [DOI] [PubMed] [PMC]

[35] Zhang J, Liu X, Meng Y, Wu H, Wu Y, Yang B, et al. Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients. Sci Rep. 2018; 8: 9442. [DOI] [PubMed] [PMC]

[36] Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Eyck LV, et al. Genetic and phenotypic spectrum associated with IFIH1 gain-of-function. Hum Mutat. 2020; 41: 837-49. [DOI] [PubMed] [PMC]

[37] Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36: 337-8. [DOI] [PubMed]

[38] PTPN22 Gene-Protein Tyrosine Phosphatase Non-Receptor Type 22 [Internet]. Weizmann Institute of Science; c1996- 2024 [cited 2024 May 23]. Available from: https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPN22&keywords=ptpn22#snp

[39] Minniakhmetov I, Yalaev B, Khusainova R, Bondarenko E, Melnichenko G, Dedov I, et al. Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem. Biomedicines. 2024; 12: 399. [DOI] [PubMed] [PMC]